- Direction
- Stable
- Own history
- 45th
- Peers
- 57th
- Persistence
- TRANSIENT
· Perfumes, Cosmetics & Other Toilet Preparations
RESEARCH SNAPSHOTCOLGATE PALMOLIVE CO's latest supported as-filed period reports revenue of $5.4B. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 2.50% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 21.81% · OPTIONAL
Yoy · gp.fundamentals.shares_outstanding
Raw value -1.38% · CORE
Yoy · gp.fundamentals.revenue
Raw value 4.64% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 40.64% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 60.22% · CORE
Level · gp.fundamentals.operating_margin
Raw value 20.26% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue increased 4.9%; Operating margin moved 218 bp lower; Operating income decreased 5.9%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents increased 12.8%; Operating cash flow increased 12.6%.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 4.6%; Operating margin moved 37 bp lower; Operating income increased 2.7%.
3 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 4.6%; Operating margin moved 37 bp lower; Operating income increased 2.7%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Capital expenditure increased 18.5%; Capex / revenue moved 27 bp higher.
2 evidence-backed componentsCash & equivalents changed +19.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
CL · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0000021665-26-000048SEC ↗8-KOct 30, 2026Period Oct 30, 20260000021665-26-000047SEC ↗4Oct 2, 2026Period Oct 1, 20260001225208-26-008102SEC ↗4Oct 2, 2026Period Oct 1, 20260001225208-26-008101SEC ↗4Oct 2, 2026Period Oct 1, 20260001225208-26-008100SEC ↗4Sep 18, 2026Period Sep 16, 20260001225208-26-007888SEC ↗4Sep 18, 2026Period Sep 16, 20260001225208-26-007887SEC ↗4Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Oct 1, 2026Filed Oct 2, 2026 | NORRINGTON LORRIE MDirector | Grant Or AwardDirect | 300 | $87 | $26,226 | Form 4 ↗ |
| Sep 16, 2026Filed Sep 18, 2026 | Wallace Noel R.Chairman, President & CEO | Grant Or AwardDirect | 29,649 | $0 | $0 | Form 4 ↗ |
| Sep 16, 2026Filed Sep 18, 2026 | Wallace Noel R.Chairman, President & CEO | Grant Or AwardDirect | 205,197 | $0 | $0 | Form 4 ↗ |
| Sep 13, 2026Filed Sep 15, 2026 | Wallace Noel R.Chairman, President & CEO | Tax WithholdingDirect | 4,892 | $87 | $424,626 | Form 4 ↗ |
| Sep 12, 2026Filed Sep 15, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Level · gp.fundamentals.sbc_revenue_ratio
Raw value 1.17% · OPTIONAL
Stockholders' equity changed -66.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Trade receivables changed +10.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed -4.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -218 basis points from the comparable as-filed period.
Total assets changed -3.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Stockholders' equity changed -66.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001225208-26-007886| Wallace Noel R.Chairman, President & CEO |
| Tax WithholdingDirect |
| 3,516 |
| $87 |
| $305,189 |
| Form 4 ↗ |
| Sep 11, 2026Filed Sep 15, 2026 | Wallace Noel R.Chairman, President & CEO | Tax WithholdingDirect | 4,071 | $87 | $353,363 | Form 4 ↗ |
| Aug 24, 2026Filed Aug 26, 2026 | Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin | Open Market SaleIndirect | 10,000 | $92 | $920,477 | Form 4 ↗ |
| Aug 6, 2026Filed Aug 7, 2026 | CAHILL JOHN TDirector | Option ExerciseDirect | 4,170 | $72 | $298,405 | Form 4 ↗ |
| Aug 6, 2026Filed Aug 7, 2026 | CAHILL JOHN TDirector | Open Market SaleDirect | 4,170 | $93 | $389,358 | Form 4 ↗ |
| Aug 6, 2026Filed Aug 7, 2026 | CAHILL JOHN TDirector | Option ExerciseDirect | 4,170 | $0 | $0 | Form 4 ↗ |
| Aug 5, 2026Filed Aug 6, 2026 | Wallace Noel R.Chairman, President & CEO | Option ExerciseDirect | 161,021 | $72 | $11.6M | Form 4 ↗ |
| Aug 5, 2026Filed Aug 6, 2026 | Wallace Noel R.Chairman, President & CEO | Open Market SaleDirect | 161,021 | $93 | $14.9M | Form 4 ↗ |
| Aug 5, 2026Filed Aug 6, 2026 | Wallace Noel R.Chairman, President & CEO | Option ExerciseDirect | 161,021 | $0 | $0 | Form 4 ↗ |
| Aug 4, 2026Filed Aug 6, 2026 | Wallace Noel R.Chairman, President & CEO | Option ExerciseDirect | 161,021 | $72 | $11.6M | Form 4 ↗ |
| Aug 4, 2026Filed Aug 6, 2026 | Wallace Noel R.Chairman, President & CEO | Open Market SaleDirect | 161,021 | $92 | $14.8M | Form 4 ↗ |
| Aug 4, 2026Filed Aug 6, 2026 | Wallace Noel R.Chairman, President & CEO | Option ExerciseDirect | 161,021 | $0 | $0 | Form 4 ↗ |
| Jul 1, 2026Filed Jul 2, 2026 | NORRINGTON LORRIE MDirector | Grant Or AwardDirect | 293 | $89 | $26,209 | Form 4 ↗ |
| Jul 1, 2026Filed Jul 2, 2026 | Newman BrianDirector | Grant Or AwardDirect | 209 | $89 | $18,695 | Form 4 ↗ |
| Jul 1, 2026Filed Jul 2, 2026 | BILBREY JOHN PDirector | Grant Or AwardDirect | 265 | $89 | $23,704 | Form 4 ↗ |
| Jun 16, 2026Filed Jun 17, 2026 | GRANT SHANECOO, Americas | Tax WithholdingDirect | 23,347 | $91 | $2.1M | Form 4 ↗ |